|
FDA-approved gadolinium-based intravenous contrast agent Clinical Trials
1 actively recruiting trial across 1 location
Also known as: gadobenate dimuglumine, gadopiclenol
Madison, Wisconsin1 trial
Study of 18F-FFNP Breast PET/MRI
UW Carbone Cancer Center
Phase 2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.